Q&A: What do the recent updates to the Declaration of Helsinki mean for clinical trial technology?
A conversation with Amanda Howley, Director of Services Solutions at Suvoda
Why eCOA belongs with IRT: connected data for mission-critical, time-sensitive moments in a clinical trial
By: Andrés Escallón, Vice President, eCOA Solutions Strategy
The Suvoda Platform: innovation and architecture that delivers simplicity and customizability
This post is the second in a two-part blog series where E.K. Koh, Chief Product Officer at Suvoda...
What is the Suvoda Platform?
This post is the first in a two-part blog serieswhere E.K. Koh, Chief Product Officer at Suvoda and...
Navigating the next wave of innovation in eCOA: Addressing operational challenges in clinical trials
Author: Andrés Escallón, Vice President of eCOA Solutions Strategy
Snapshot:
- Streamlined o...
How eCOA enhances data management in clinical trials
Author: Andrés Escallón, Vice President of eCOA Solutions Strategy
Snapshot:
- Higher data quality...
2025 Big ideas in clinical trials: a conversation with Suvoda's leaders
Author: Elena Filimonova, Chief Marketing Officer
Snapshot:
- Patient-centricity and technological...
The impact of eCOA in gastrointestinal clinical trials
Author: Jill V. Platko PhD, Vice President, Scientific Services
Snapshot:
- Advantages of Timely...
The power of eCOA in dermatology clinical trials
Author: Jill V. Platko PhD, Vice President, Scientific Services
Snapshot:
- Fluctuating Symptoms...
